CME webinar: Suicide and Depression in the Primary Care Office (recorded)

Mar. 2023Education/Webinars
"What the webinar will cover*
  • Information on the prevalence of depression, suicide, and suicidal thoughts and behaviors from a state and national perspective
  • How to incorporate routine screenings for depression and suicide into daily practice
  • A multipronged approach in the treatment for depression and suicide in primary care
  • How to determine when and how to refer to behavioral health services
  • The spectrum of UPMC Health Plan resources that support behavioral health conditions

Presenters:
Geoff Neimark, MD
Chief Medical Officer
Community Care Behavioral Health Organization

Nicholas DeGregorio, MD, MMM, FACP
AVP, Medicaid Medical Services
UPMC Health Plan

Watch now
Watch the recording of the Suicide and Depression in the Primary Care Office webinar.

Provider is responsible for verifying continuing medical education (CME) eligibility.

*This activity is approved for AMA PRA Category 1.5 Credits™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity."

Recent Announcements

Clinical workflow changes through Epic®

Changes are coming for network providers that utilize Provider OnLine to submit specific information to UPMC Health Plan. Select activities that were previously completed in Provider OnLine will now transition to UPMC Health Plan Tapestry Link.
Sep. 2026Important Notices

CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care

Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.
Sep. 2026Education/Webinars

Voluntary nationwide recall: Thyroid (Vitruvias – August 2026)

Vitruvias Therapeutics Inc. is recalling one lot, lot 504950, of Thyroid Tablets, USP 30 mg. Thyroid Tablet is used to treat hypothyroidism (underactive thyroid).
Sep. 2026Pharmacy Updates